Dr. Hay is a Hematologist and clinician scientist within the Department of Medicine, cross appointed to the Department of Oncology,and the Department of Pediatrics and a Senior Investigator with the Canadian Cancer Trials Group. Having completed medical and hematology training in Scotland, Dr. Hay undertook 2 ½ years of fellowship with the Canadian Cancer Trials Group, transitioning to a Senior Investigator position in 2014. In this role her responsibilities include development and conduct of clinical trials for patients with hematological malignancies, economic evaluations of cancer interventions, and improving opportunities for adolescents and young adults with cancer to participate in clinical research. Interests also include exploration of more efficient means to conduct clinical trials, whilst upholding patient privacy and safety.
Areas of expertise:Clinical trials, myeloma, lymphoma, leukemia, data sharing and linkage, adolescents and young adults with cancer, health economics, CAR T-cell therapy
Research interests: Clinical trials, myeloma, lymphoma, leukemia, CAR T-cell therapy, data sharing and linkage, health economics
Current trials: MYX1, IND216, SI612 (ALC5), CLC2E, SRC6, LY15, LY17, LY18
For a full list of publications please visit PubMed